Parallel Advisors, LLC Cti Biopharma Corp Transaction History

Parallel Advisors, LLC

  • $3.67 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 20, 2024
BUY
$4.2 - $6.01 $491 - $703
117 New
117 $0
Q1 2023

Apr 25, 2023
BUY
$4.2 - $6.01 $352 - $504
84 Added 254.55%
117 $0
Q4 2022

Feb 03, 2023
BUY
$4.45 - $6.17 $146 - $203
33 New
33 $0
Q2 2022

Aug 01, 2022
BUY
$3.55 - $6.27 $102 - $181
29 New
29 $0

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email